Once construction is complete in 2032, the company plans on creating some of its "biggest medicines" at the new facility.
Fennec Pharmaceuticals is a commercial-stage oncology supportive-care company centered on Pedmark/Pedmarqsi. Read why FENC stock is a Buy.
Marshall is CFO and treasurer at Lantheus Holdings, a publicly-traded pharmaceutical company based in Billerica.
Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture (Ohito) ...
The market for weight-loss drug is expected to expand to more than $150 billion in revenue by the early 2030s, thanks to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback